Clinical trial
The Effects of OC000459 on Nasal Mediators
NCT00290381 · Trevor Hansel, Other · Completed
Key facts
| NCT number | NCT00290381 |
|---|---|
| Title | The Effects of OC000459 on Nasal Mediators |
| Official title | The Effects of OC000459 on Nasal Th2 Cytokine Release, Eosinophil Responses, and Nasal Symptoms After Nasal Allergen Challenge (NAC) With Timothy Grass Pollen in Subjects With Allergic Rhinitis Out of Season |
| Lead sponsor | Trevor Hansel, Other |
| Collaborators | Oxagen Ltd Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Allergic Rhinitis |
| Intervention type | Procedure |
| Interventions | Oxagen OC000459 |
| Enrollment | 12 |
| Primary completion | Feb 1, 2005 |
| First posted | Feb 13, 2006 |
| Last update posted | Oct 30, 2023 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: